Clinical Trial

A Trial to Evaluate KPC000154 Tablets in Healthy Subjects

Name: A Trial to Evaluate KPC000154 Tablets in Healthy Subjects — clinical trial record (NCT06867406)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: KPC000154

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated March 10, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.

Summary

A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of KPC000154 Tablets in Healthy Subjects

Trial Details

NCT Number	NCT06867406
Lead Sponsor	Kunming Pharmaceuticals, Inc.
Conditions	Healthy Subjects、Lipid Metabolism
Enrollment	92 participants
Start Date	2025-03-07
Primary Completion	2025-11-30 (estimated)
Study Completion	2026-01-31 (estimated)
Updated on ClinicalTrials.gov	2025-03-10